| Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target L Peyrin-Biroulet, W Sandborn, BE Sands, W Reinisch, W Bemelman, ... Official journal of the American College of Gastroenterology| ACG 110 (9 …, 2015 | 1896 | 2015 |
| Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial SP Costello, PA Hughes, O Waters, RV Bryant, AD Vincent, P Blatchford, ... Jama 321 (2), 156-164, 2019 | 771 | 2019 |
| Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up RV Bryant, DC Burger, J Delo, AJ Walsh, S Thomas, A von Herbay, ... Gut 65 (3), 408-414, 2016 | 402 | 2016 |
| Systematic review: histological remission in inflammatory bowel disease. Is ‘complete’remission the new treatment paradigm? An IOIBD initiative RV Bryant, S Winer, T SPL, RH Riddell Journal of Crohn's and Colitis 8 (12), 1582-1597, 2014 | 335 | 2014 |
| Systematic review with meta‐analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis SP Costello, W Soo, RV Bryant, V Jairath, AL Hart, JM Andrews Alimentary pharmacology & therapeutics 46 (3), 213-224, 2017 | 298 | 2017 |
| consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ... Alimentary pharmacology & therapeutics 46 (11-12), 1037-1053, 2017 | 281 | 2017 |
| Current best practice for disease activity assessment in IBD AJ Walsh, RV Bryant, SPL Travis Nature reviews Gastroenterology & hepatology 13 (10), 567-579, 2016 | 235 | 2016 |
| Systematic review: body composition in adults with inflammatory bowel disease RV Bryant, MJ Trott, FD Bartholomeusz, JM Andrews Alimentary pharmacology & therapeutics 38 (3), 213-225, 2013 | 205 | 2013 |
| Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding RV Bryant, P Kuo, K Williamson, C Yam, MN Schoeman, RH Holloway, ... Gastrointestinal endoscopy 78 (4), 576-583, 2013 | 167 | 2013 |
| Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application RV Bryant, AB Friedman, EK Wright, KM Taylor, J Begun, G Maconi, ... Gut 67 (5), 973-985, 2018 | 166 | 2018 |
| Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease RV Bryant, S Ooi, CG Schultz, C Goess, R Grafton, J Hughes, A Lim, ... Alimentary pharmacology & therapeutics 41 (9), 895-906, 2015 | 158 | 2015 |
| Development of synthetic jet actuators for active flow control at NASA Langley FJ Chen, C Yao, G Beeler, R Bryant, R Fox Fluids 2000 Conference and Exhibit, 2405, 2000 | 119 | 2000 |
| Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status RV Bryant, DR Van Langenberg, GJ Holtmann, JM Andrews Journal of gastroenterology and hepatology 26 (5), 916-923, 2011 | 117 | 2011 |
| How to perform gastrointestinal ultrasound: Anatomy and normal findings NSS Atkinson, RV Bryant, Y Dong, C Maaser, T Kucharzik, G Maconi, ... World journal of gastroenterology 23 (38), 6931, 2017 | 96 | 2017 |
| WFUMB position paper. Learning gastrointestinal ultrasound: theory and practice NSS Atkinson, RV Bryant, Y Dong, C Maaser, T Kucharzik, G Maconi, ... Ultrasound in medicine & biology 42 (12), 2732-2742, 2016 | 87 | 2016 |
| NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease T Schwerd, RV Bryant, S Pandey, M Capitani, L Meran, JB Cazier, J Jung, ... Mucosal immunology 11 (2), 562-574, 2018 | 85 | 2018 |
| An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials C Ma, R Sedano, A Almradi, NV Casteele, CE Parker, L Guizzetti, ... Gastroenterology 160 (7), 2291-2302, 2021 | 84 | 2021 |
| Conventional drug therapy for inflammatory bowel disease RV Bryant, O Brain, SPL Travis Scandinavian journal of gastroenterology 50 (1), 90-112, 2015 | 78 | 2015 |
| Defining transabdominal intestinal ultrasound treatment response and remission in inflammatory bowel disease: systematic review and expert consensus statement JFKF Ilvemark, T Hansen, TM Goodsall, JB Seidelin, H Al-Farhan, ... Journal of Crohn's and Colitis 16 (4), 554-580, 2022 | 75 | 2022 |
| Introducing vedolizumab to clinical practice: who, when, and how? RV Bryant, WJ Sandborn, SPL Travis Journal of Crohn's and Colitis 9 (4), 356-366, 2015 | 74 | 2015 |
